Predictive Value of Serum Infliximab Levels at Induction Phase in Rheumatoid Arthritis Patients.

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/30911

Title:	Predictive Value of Serum Infliximab Levels at Induction Phase in Rheumatoid Arthritis Patients.
Authors:	Teresa, Jurado Chamaida, Plasencia-Rodríguez Ana, Martínez-Feito Victoria, Navarro-Compán Theo, Rispens Annick, Vries Karien, Bloem Eva-María, Olariaga Cristina, Diego Alejandro, Villalba Diana, Peiteado Laura, Nuño Maria-Gema, Bonilla Alejandro, Balsa Dora, Pascual-Salcedo View more
Keywords:	Early immunogenicity Induction phase Infliximab therapy Levels clearance Loss of efficacy Rheumatoid Arthritis View more
Issue Date:	2017
Citation:	Open Rheumatol J.2017;(11):75-87
Abstract:	The Infliximab, has proven effective in treating rheumatoid arthritis (RA). A good clinical response is usually associated with high serum drug levels. Development of antibodies toward Infliximab (ATI) can increase drug clearance, leading to treatment failure.
PMID:	28761564
URI:	https://hdl.handle.net/20.500.12530/30911
Rights:	openAccess
ISSN:	1874-3129
Appears in Collections:	Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos

Files in This Item:

File	Description	Size	Format
PMC5510569.pdf		7.79 MB	Adobe PDF	View/Open